ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
2,2,Otitis externa,Ear infections,Infections - pathogen unspecified,Infec,N
3,1,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
4,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
5,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
6,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
7,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
8,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
9,1,Otitis externa,Ear infections,Infections - pathogen unspecified,Infec,N
10,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
11,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
12,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
13,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
14,1,Otitis externa,Ear infections,Infections - pathogen unspecified,Infec,N
15,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
16,1,Otitis externa,Ear infections,Infections - pathogen unspecified,Infec,N
17,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
18,1,Inflammation,Inflammations,General system disorders NEC,Genrl,N
19,1,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
20,1,Middle ear disorder,Middle ear disorders NEC,Middle ear disorders (excl congenital),Ear,N
20,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
21,1,Application site burn,Application site reactions,Administration site reactions,Genrl,N
21,2,Application site pain,Application site reactions,Administration site reactions,Genrl,N
21,3,Deafness,Hearing losses,Hearing disorders,Ear,N
21,4,Otitis externa,Ear infections,Infections - pathogen unspecified,Infec,N
21,5,Otorrhoea,Ear disorders NEC,Aural disorders NEC,Ear,N
21,6,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
22,1,Deafness,Hearing losses,Hearing disorders,Ear,N
22,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
23,1,Deafness,Hearing losses,Hearing disorders,Ear,N
24,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
24,2,Scab,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
24,3,Skin haemorrhage,Skin haemorrhages,Skin vascular abnormalities,Skin,N
24,4,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
25,1,Deafness,Hearing losses,Hearing disorders,Ear,N
25,2,Ear pain,Ear disorders NEC,Aural disorders NEC,Ear,N
26,1,Deafness,Hearing losses,Hearing disorders,Ear,N
26,2,Ear pain,Ear disorders NEC,Aural disorders NEC,Ear,N
